Author:
Carter James G.,Gammons Melissa V. R.,Damodaran Gopinath,Churchill Amanda J.,Harper Steven J.,Bates David O.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Biochemistry,Physiology
Reference25 articles.
1. Artac RA, McFee RM, Smith RAL, Baltes-Breitwisch MM, Clopton DT, Cupp AS (2009) Neutralization of vascular endothelial growth factor antiangiogenic isoforms is more effective than treatment with proangiogenic isoforms in stimulating vascular development and follicle progression in the perinatal rat ovary. Biol Reprod 81(5):978–988
2. Bates DO, Catalano PJ, Symonds KE, Varey AHR, Ramani P, O’Dwyer PJ, Giantonio BJ, Meropol NJ, Benson AB, Harper SJ (2012) Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab. Clin Cancer Res 18(22):6384–6391
3. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ (2002) VEGF(165)b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62(14):4123–4131
4. Bates DO, MacMillan PP, Manjaly JG, Qiu Y, Hudson SJ, Bevan HS, Hunter AJ, Soothill PW, Read M, Donaldson LF, Harper SJ (2006) The endogenous anti-angiogenic family of splice variants of VEGF, VEGF(xxx)b, are down-regulated in pre-eclamptic placentae at term. Clin Sci 110(5):575–585
5. Bhattacharjee G, Asplin IR, Wu SM, Gawdi G, Pizzo SV (2000) The conformation-dependent interaction of alpha(2)-macroglobulin with vascular endothelial growth factor—a novel mechanism of alpha(2)-macroglobulin/growth factor binding. J Biol Chem 275(35):26806–26811
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献